Skip to search formSkip to main contentSkip to account menu

Cyclooxygenase 2 Inhibitors

Known as: Cyclooxygenase-2 Inhibitors, Inhibitors, COX2, COX2 Inhibitors 
A nonsteroidal anti-inflammatory drug used to relieve pain and inflammation. COX-2 inhibitors are being studied in the prevention of colon polyps… 
National Institutes of Health

Related topics

Related topics

13 relations

Narrower (9)

Etodolaccelecoxibetoricoxiblumiracoxib
In Bloodaspects of radiation effectschemical synthesisstandards characteristics

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Induction of apoptosis by celecoxib in cell culture: an uncertain role for cyclooxygenase-2.
To the Editor: A recent report by Kern et al. ( [1][1]) described molecular mechanisms of apoptosis in human hepatocellular… 
2006
2006
Synthesis and Pharmacological Evaluation of Some Dual‐Acting Amino‐alcohol Ester Derivatives of Flurbiprofen and 2‐[1,1′‐Biphenyl‐4‐yl]acetic Acid: A Potential Approach to Reduce Local…
The search for safer non‐steroidal anti‐inflammatory drugs (NSAIDs) continues with the failure of anticipated ‘ideal’ anti… 
Review
2005
Review
2005
Monocyte cyclooxygenase-2 activity: a new therapeutic target for atherosclerosis?
It is now widely accepted that atherosclerosis is a complex chronic inflammatory disorder of the arterial tree associated with… 
2005
2005
Researchers plan to continue to study COX-2 inhibitors in cancer treatment and prevention.
2004
2004
COX-2 inhibitor use after Vioxx: careful balance or end of the rope?
2003
2003
Acute renal failure after administration of a single dose of a highly selective COX-2 inhibitor.
2002
2002
Recent pharmacodynamic and pharmacokinetic findings on oxaprozin
Oxaprozin has proven a safe and effective treatment for arthritic conditions. It has a low incidence of gastrointestinal side… 
2001
2001
NSAID Hypersensitivity in the COX-2 Inhibitor Era
1999
1999
DOCTOR AND PATIENT EXPLORING CLINICAL THINKING. By Ken Cox
1997
1997
Apoptosis induction and inhibition of colon-26 tumour growth and angiogenesis: findings on COX-1 and COX-2 inhibitors in vitro & in vivo and topical diclofenac in hyaluronan.
The chronic administration of non-steroidal anti-inflammatory drugs (NSAIDs) results in reduced colonic adenocarcinoma incidence1…